ReNAgade Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- ReNAgade Therapeutics's estimated annual revenue is currently $19.8M per year.
- ReNAgade Therapeutics's estimated revenue per employee is $155,000
Employee Data
- ReNAgade Therapeutics has 128 Employees.
- ReNAgade Therapeutics grew their employee count by 22% last year.
ReNAgade Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | COO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | Chief Scientific Officer Gene Editing | Reveal Email/Phone |
5 | SVP, Chemistry and Delivery | Reveal Email/Phone |
6 | VP, Toxicology & Pathology | Reveal Email/Phone |
7 | VP, Translational Sciences at ReNAgade Therapeutics | Reveal Email/Phone |
8 | VP, Legal and IP | Reveal Email/Phone |
9 | VP, Head Immunology | Reveal Email/Phone |
10 | Head Computational Biology and Machine Learning | Reveal Email/Phone |
ReNAgade Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is ReNAgade Therapeutics?
ReNAgade is building a next generation RNA company that is modality agnostic
keywords:N/AN/A
Total Funding
128
Number of Employees
$19.8M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $41.6M | 128 | 1% | N/A |
#2 | $17.9M | 128 | 7% | N/A |
#3 | $25.7M | 128 | 39% | N/A |
#4 | $25.7M | 128 | 39% | N/A |
#5 | $28.4M | 129 | 1% | N/A |